Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 19.80M | $ 9.90M | $ 5.80M | $ 3.60M | $ 14.70M |
Total Assets | $ 620.10M | $ 596.20M | $ 531.50M | $ 509.30M | $ 541.40M |
Total Debt | $ 26.90M | $ 28.30M | $ 32.30M | $ 42.20M | $ 62.80M |
Net Debt | $ 7.10M | $ 18.40M | $ 26.50M | $ 38.60M | $ 48.10M |
Total Liabilities | $ 202.00M | $ 208.00M | $ 178.70M | $ 172.60M | $ 211.80M |
Stockholders Equity | $ 418.10M | $ 388.20M | $ 352.80M | $ 336.70M | $ 329.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |